The official government statistics claims that 33 million people, every
year siide below poverty line owing to Healthcare expenditure. This
clearly indicates the intensity of the problem and the huge implication
on the nation. Provision of quality health care is high on government's
agenda through the provision of various schemes. Provision of Health
insurance ensures the provision of quality Healthcare minus the
additional burden on the consumer.
magine the anguish of a family with income to merely take care of their essential needs when faced with life threatening ailment in his family. Overnight this person needs to divert his income for medical purposes and there is good chance that he ends up selling all his assets accumulated over years. There is a good chance of some such families slipping into BPL category. If you think that this is a story, hold your breadth, this happens in reality in India. 33 million people slide below poverty line every year owing to Healthcare expenditure and this is the official government
statistics. This clearly implies the magnitude of the problem and the huge implication on the nation if timely corrective action is not taken. It is the possible genesis of social unrest.
Given the emphasis of the Government on Social and Financial Inclusion, provision of quality health care is high on government's agenda. Through schemes like National Rural Health Mission (NRHM) and Rashtriya Swasthya Bima Yojana (RSBY), Arogyashree, etc a change is certainly being felt. The speed of change however needs to be accelerated in view of the magnitude of the problem.
Provision of Health insuran is a key financing mechanis in ensuring the provision quality healthcare without putt additional burden on consur pocket. Government, Regi and Private sector are all invc in creating right environr and products for development vibrant health insurance marke India and a lot has been achiey too. A lot however, yet rema to be done before we can assume that consumer is a kir this space.
Both Health providers Insurers have their proble especially in terms of claim,settlements, ever rising medical cost, lack of transparency and standardization of various parameters et al. Both the sides also have their ways of ensuring viability of their business model through various means.
It is ultimately the consumer who suffers as result of information gap between the payer and the provider. Most of the times, consumer is bogged down with issues like difficulty in getting claims., uncertainty about benefits, insurance being more beneficial to hospitals than patients, important ailments not covered, meant for rich, educated and those in business etc.The change in consumer mindset is possible only if these issues are taken care of.
How is this possible?
FICCI in its quest to provide "justice to the consumer" embarked on the exercise of identifying the causes of friction between the health providers and insurers and work on developing ways and means of plugging the differences between the two sides in a manner that the consumer interest is upheld. FICCI was supported in this activity by the Insurance regulator i.e. Insurance Regulatory and Development Authority (IRDA), numerous clinical experts and health providers, life insurance council, general insurance counc)), a large number of insurance Companies, TPAs et al.
A group comprising of all the above mentioned stakeholders was constituted to enable FICCI in conducting the pioneering work in creating standards for the key areas in the health ecosystem:
Development of Standard Treatment Guidelines (STGs) for common reasons of hospitalization. The aim of these treatment guidelines are to reduce claim disputes substantially by providing a reference framework for payers to process medical claims for these conditions and thus reducing the needs for queries moving back and forth between payers and providers. This could enable increased automation of claims handling resulting in faster claim processing and reduction of TATs (turn around time) for a significant proportion of claims. Further, these cou\d help in setting appropriate grades/ levels of payout for different types of surgeries in fixed benefit plans and setting scientific and reasonable sub-limits for different procedures in reimbursement plans while providing a framework for development of appropriate price range for these conditions in different situations. Above all this would also ensure that consumer is provided the essential medical attention while avoiding over diagnosis and under treatment.
Standardization of definitions of Critical Illnesses for Indian Insurance Industry - This, we believe, will help resolve the confusion in the minds of the consumer arising out of varying definitions adopted by different companies and give them clear parameters for selection of right product. It would thus help enhance consumer satisfaction significantly.
Standardization of list of expenses of expenses generally excluded ('non medical expenses" in hospitalization indemnity Policy - The aim is to minimize the ambiguity and subjectivity in deductions from hospital bills, which will improve the understanding for such expenses amongst patients, providers and insurers/Third party Administrators (TPAs). The consumer would be aware of the excluded items from the inception and will not get caught in the crossfire between the payer and the provider.
How does this work benefit all the stakeholders?
This transparency will help reduce the acrimony between the payer and the provider thus helping the consumer to have realistic expectation from the Insurance product. Also, this exercise would lead to more innovation in product creation, awareness and enhancement of health Insurance market at large.
The FICCI initiative has enabled a constructive dialogue between the Health provider, insurer and TPA which has hitherto been missing. So far all the stakeholders have been focusing on individual growth that was hindering the collective growth of the sector.
The consensus exercise created under FICCI banner would have multiplier impact on the growth of Health Insurance market in India catering to a huge lower and middle income group comprising 61.9 per cent of the total Indian population hitherto unattended, apart from supporting the Government initiatives focused towards BPL category.
Courtesy. FICCI Health Services & Financial Services Divisions
|
History
Originally studied since the late 1930s as an immunological
neurological disorder under the medical term "myalgic
encephalomyelitis" (ME), CFS has been classified by the World Health
Organization (WHO) as a disease of the central nervous system since
1969. In 1992 and early 1993 the terms "post-viral fatigue syndrome"
(PVFS) and "chronic fatigue syndrome" (CFS) were added to ME under the
exclusive ICD-10 designation of G93.3. This is an artifact of the WHO
not allowing multiple categorizations of a single condition, rather
than being an indication of two disjoint disorders. |

|
Nomenclature
There are a number of different terms which have been at various times
identified with this organic neuroimmune disorder.Myalgic encephalomyelitis (ME, "inflammation of the brain and spinal
cord with muscle pain") as a disease entity has been recognized and
described in the medical literature since 1938, with the seminal paper
being that by Wallis in 1957; Sir Donald Acheson's (a former Chief
Medical Officer) major review of ME was published in 1959; in 1962 the
distinguished neurologist Lord Brain included ME in his textbook of
neurology, and in 1978 the Royal Society of Medicine accepted ME as a
distinct clinical entity.
In 1988 both the UK Department of Health and
Social Services and the British Medical Association officially
recognized it as a legitimate and potentially distressing disorder.
Opponents to the term ME maintain there is no inflammation and that
not all patients report muscle pain. United Kingdom and Canadian
researchers and patients generally use this term in preference to CFS.
Chronic fatigue syndrome (CFS); this name was introduced in 1988 by a
group of United States researchers based at the Centers for Disease
Control and Prevention, and is used increasingly over other
designations, particularly in the United States.
Chronic fatigue immune dysfunction syndrome (CFIDS); many people,
especially patients in the United States, use the term CFIDS
(pronounced [See-Fids]), which was originally an acronym for the above
or "Chronic Fatigue & Immune Dysregulation Syndrome". This term was
introduced by patients current with the biomedical research in an
attempt to reduce the psychiatric stigma attached to "chronic
fatigue", as well as the public perception of CFS as a psychiatric
syndrome.
Post-viral [fatigue] syndrome (PVS or PVFS); this is a related
disorder. According to original ME researcher Dr. Melvin Ramsay, "The
crucial differentiation between ME and other forms of post-viral
fatigue syndrome lies in the striking variability of the symptoms not
only in the course of a day but often within the hour. This
variability of the intensity of the symptoms is not found in
post-viral fatigue states" (Ramsay 1989).
Chronic Epstein-Barr virus (CEBV) or Chronic Mononucleosis; the term
CEBV was introduced by virologists Dr. Stephen Straus and Dr. Jim
Jones in the United States. The Epstein-Barr virus, a neurotropic
virus that more commonly causes infectious mononucleosis, was thought
by Straus and Jones to be the cause of CFS. Subsequent discovery of
the closely related human herpesvirus 6 shifted the direction of
biomedical studies, although a vastly expanded and substantial body of
published research continues to show active viral infection or
reinfection of ME/CFS patients by these two viruses. As these viruses
are also found in healthy controls, however, it is uncertain what role
they play in CFS.
Low Natural Killer cell disease; this name is used widely in Japan. It
reflects research showing a reduction in the number of natural killer
cells in many CFS patients.
Yuppie Flu; this was a factually inaccurate nickname for CFS, first
published in a November 1990 Newsweek article. It reflects the belief
that CFS mainly affects the affluent ("yuppies"), and implies that it
is a form of malingering or burnout. CFS, however, affects people of
all races, genders, and social standings, and this nickname is
inaccurate and considered offensive by patients. It is likely that
this article contributed to the damaging public (and even medical)
perception of CFS as a psychiatric or even psychosomatic condition.
Uncommonly used terms include Akureyri Disease, Iceland disease (in
Iceland), Royal Free disease (after the location of an outbreak),
raphe nucleus encephalopathy, and Tapanui flu (after the New Zealand
town Tapanui where the first doctor in the country to investigate the
disease, Dr Peter Snow, lived).
Symptoms
According to the 1994 Fukuda definition there are eight main
categories of symptoms in CFS:
Fatigue: People with CFS experience profound, overwhelming exhaustion,
both mental and physical, which is worsened by exertion, and is not
relieved (or not completely relieved) by rest. To receive a diagnosis
of CFS, this fatigue state must last for six months.
Pain: Pain in CFS may include muscle pain, joint pain (without joint
swelling or redness, and may be transitory), headaches (particularly
of a new type, severity, or duration), lymph node pain, sore throats,
and abdominal pain (as a symptom of irritable bowel syndrome).
Patients also report; bone, eye and testicular pain, neuralgia and
painful skin sensitivity. Chest pain has been attributed variously to
microvascular disease or cardiomyopathy by researchers.
Cognitive problems: people with CFS may experience forgetfulness,
confusion, difficulty thinking, concentration difficulties, and
"mental fatigue" or "brain fog". Additional signs may be experienced;
in the 2003 Canadian Definition these include aphasia, agnosia, loss
of cognitive body map.
Hypersensitivity: people with CFS are often sensitive to light, sound,
and some chemicals and foods. Many CFS patients report an increase in
allergic-type sensitivity to foods, scents, and products, and many
also report a sensitivity to medications, which can complicate
treatment. Patients with pre-existing allergies, asthma, and similar
conditions often report a worsening of symptoms. A remarkable feature
of "classically defined" ME are "sensory storms", typified by sudden
catastrophic incapacitation to noise, light, smell, which feels
overwhelming; more pronounced as discrete earlier on in the illness.
Poor temperature control: people with CFS often report either running
too hot or too cold, possibly due to involvement of the hypothalamus,
which regulates body temperature. Many CFS patients frequently run a
low fever, or report fever-like symptoms (sweating, feeling too hot or
cold, etc.) without measurable fever temperature.
Sleep problems: "Unrefreshing sleep" and rest is a hallmark of CFS,
and in one of the syndrome's greatest ironies, insomnia is also
common, especially in the chronic phase. Maintaining a sleep schedule
is extremely difficult for many patients. Vivid, "feverish" dreams are
a symptom in many people with CFS, exacerbating disturbed sleep
patterns. A hallmark sign of neurological disease is that exercise
worsens the insomnia, i.e. the opposite to that found in well people.
Psychological/Psychiatric symptoms: emotional lability, anxiety,
depression, irritability, sometimes a curious emotional "flattening",
may manifest in CFS patients. It is undetermined whether any of these
are directly caused by the CFS mechanism, or may be secondary symptoms
created by the syndrome, as many chronic pain or illness patients also
show similar psychiatric issues. However the exaggerated and sometimes
random nature of emotional expression is consistent with some brain
disease.
Disturbances in the autonomic nervous system and hormones:
People with CFS often have abnormalities in the autonomic nervous
system such as low blood volume, orthostatic intolerance, dizziness
and light-headedness, especially when standing up quickly.
Hormonal abnormalities may include abnormal vasopressin metabolism and
a blunted ACTH response leading to hypothyroidism and/or low cortisol
and reduced ability to respond to physiological and emotional stress.
Patients sometimes show abnormally low levels of testosterone, growth
hormone and other important hormones.
It should be noted that lists of diagnostic criteria (such as the
Oxford and Fukuda lists) were designed for selection and exclusion of
participants for research studies and, as such, are quite narrow in
scope. Some patients have CFS despite the fact that their symptoms do
not match the strict research diagnostic criteria.
Onset
Some cases of CFS start gradually, but the majority start suddenly,
often triggered by a 'flu-like viral or similar illness. People with
CFS may improve or recover completely after a few or many years, or
not at all. It is not known whether any CFS sufferer has truly
recovered to pre-illness levels, or whether their symptoms have merely
subsided enough for them to live a more normal life. Some sufferers
have a remission for months or years only to later relapse, often more
Sudden onset cases
Many people with CFS report a sudden, drastic start to their illness.
Some people can remember a specific day or even hour when they first
became ill.
Often CFS starts with, or is triggered by, another illness. Many
people report getting a case of the 'flu', exposure to an allergen (a
cough or sniffle caused by paint, a new pet, or construction dust), or
a severe infection such as bronchitis, from which they seem never to
fully recover and which slowly evolves into CFS. Other patients begin
with Lyme disease, which despite adequate Lyme treatment, may 'evolve'
from the clinical symptoms and definition of Lyme to those of CFS
(this is permitted by the Fukuda definition). Other triggers can
include car accidents, moving house, and stressful life situations.
Some patients say they felt unusual or uneasy for a short period (days
or weeks) before the onset.
Gradual onset
Other cases have a very slow, gradual onset, sometimes spread over
years. People with gradual onsets may not realize there is anything
wrong for quite some time. Patients may believe they have a minor
illness, or ascribe their weakened condition to stress, and assume
they will improve with time. It is only when the patient realized that
their condition is truly debilitating, or the stress is removed and
the symptoms remain, that the patient will begin to seek treatment.
There is no standard course for CFS. For a patient to be officially
diagnosed with chronic fatigue syndrome, the symptoms must have
persisted for at least six months. It is possible that not all cases
of CFS are chronic: some people may have CFS for four months, recover,
and never get diagnosed, some claim. However, the Fukuda paper also
contains a definition of "chronic fatigue" which is reserved for those
who do not meet the full criteria for CFS. Since the 50% rule of
Holmes et al was dropped, it is possible that there are people with
CFS whose level of disability is so low that they never seek
treatment, or receive an accurate diagnosis, though this is not
permitted by the Canadian definition.
Activity levels
Activity levels vary widely among CFS patients. While some are able to
lead a relatively normal and active life, others are totally bed-bound
and unable to care for themselves. Almost all patients find they must
drastically reduce their activity from pre-illness levels, regardless
of their previous level of athleticism, and must severely modify or
give up physical hobbies and exercise. Many patients find themselves
unable to work full-time, or at all. A considerable number of CFS
cases in many countries are on disability benefits or private
insurance, or have made claims and been denied.
One notable CFS sufferer is soccer legend Michelle Akers, who reported
struggling with the illness for many of the later years of her career.
However, more severe sufferers felt that an active professional
athlete "poster child" like Akers helped to trivialize the syndrome in
the eyes of the public, and made it much more difficult for highly
incapacitated patients to be taken seriously. It is worth noting that
the condition can strike persons of all activity levels, however.
Post-exertion symptom exacerbation
One of the most common and recognizable aspects of CFS is what is
called "post-exertional malaise". When people with CFS exert
themselves beyond their limits (and their limits may change daily),
their symptoms worsen. The harder the exertion and the longer it
lasts, the worse the symptoms will be afterward with greater recovery
time. Some contend from this that prognoses such as deterioration or
relapse-remission must be due to sufferers' activity patterns, however
this is far from proven, since in many sufferers at least,
fluctuations are not solely related to exertion but can include
responses to infection, changes in temperature (e.g. hot or cold
weather), physical or emotional stressors, and unknown disease
process, but they maintain:
The cyclical pattern occurs when patients work harder because they
"feel better" or are having a "good day", leading them to think they
can exert themselves more than usual. However, the excess exertion
leads to worse symptoms on the following day. Thus it is difficult for
patients to maintain an even level of activity, or to tell if they are
improving.
In sufferers without a diagnosis of CFS, or a proper understanding of
how CFS affects exertion, this can lead to a "downward spiral", where
a sufferer will try to work harder to make up for the previous day's
lack instead of resting. This exhausts them further, and often can
trigger a relapse or worsening of their condition.
However, many sufferers who are severely affected particularly find
this "behaviourist" hypothesis simplistic and offensive as it leads to
the blaming of patients and denial of social support and medical care
since the condition can be seen as supposedly self-controllable and
self-limiting and already scarce services may be withdrawn if the
sufferer is unfortunate enough to deteriorate.
Duration
People with CFS may improve after a few months, or after many years,
or never at all. They may reach a plateau at some constant level of
health, or may progressively decline, although CFS does not appear to
be directly fatal or damagingly progressive. Often, the symptoms
change over time, or cycle through time. Relapses are common,
especially after stressful life events or additional illness. Exertion
can cause not merely a relapse, but a worsening of overall health.
Un-diagnosed cases of CFS often worsen as the sufferer attempts to
return to a 'normal' level of activity, only to make their condition
worse through exertion.
Diagnosis
At this time, there is no accepted conclusive test or series of tests
of chronic fatigue syndrome. CFS is therefore largely an exclusionary
diagnosis. If a doctor suspects a patient may have CFS they should
begin the diagnostic process by eliminating other potential causes of
the patient's symptoms. "Chronic fatigue" and similar symptoms can be
caused by a wide variety of conditions which should be investigated,
although treatment of the patient's symptoms can begin before a
complete diagnosis is made. In a patient displaying CFS symptoms,
fatigue and new migraines, for example, it is safe and reasonable to
treat the migraines while attempting to rule out other possible causes
of the patient's fatigue.
Additional symptoms
The fatigue must be accompanied by a minimum of 4 of the following
eight symptoms:
1) Impairment of short-term memory and concentration
2) Sore throat
3) Tender lymph nodes
4) Muscle pain
5) Multi-joint pain
6) Headaches of a new type, pattern, or severity
7) Unrefreshing sleep
8) Post-exertional malaise (fatigue lasting more than 24 hours after exertion)
Treatment
Immune enhancers: These are generally "food supplements" of various
types that are claimed to enhance the immune system, although they can
include various antiviral drugs. They are often proposed either to
treat some presumed viral infection or to treat a presumed general
immune deficiency.
Notable sufferers
Some notable persons with CFS are:
Michelle Akers, soccer player
Brian Aldiss, author
Susan Blackmore, parapsychologist, author
Howard Bloom, evolutionary psychologist, author
Cher, pop singer, actress
Neil Codling, formerly of Suede
Blake Edwards, writer and director of such movies as Breakfast at
Tiffany's, 10, and The Pink Panther
John Fahey, folk guitarist
Flea, musician
Kelly Holmes, athlete
(Compiled from Internet by J4K Amenities Research Team)
|